BioTroy Therapeutics
Lingan
About BioTroy Therapeutics
BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $42.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2025)
- Website: biotroy.com
- Phone: 185-1569-5111
Industries & Categories
Health Care, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/biotroy-therapeutics-35670 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.